EP 2124899 A2 20091202 - STABLE PHARMACEUTICAL FORMULATIONS OF ATORVASTATIN MAGNESIUM SALT
Title (en)
STABLE PHARMACEUTICAL FORMULATIONS OF ATORVASTATIN MAGNESIUM SALT
Title (de)
STABILE PHARMAZEUTISCHE FORMULIERUNGEN VON ATORVASTATIN-MAGNESIUMSALZ
Title (fr)
FORMULATIONS PHARMACEUTIQUES STABLES DE SEL D'ATORVASTATINE MAGNÉSIUM
Publication
Application
Priority
- IS 2007000024 W 20071221
- IS 8587 A 20061227
Abstract (en)
[origin: WO2008078341A2] Stable pharmaceutical formulations are provided comprising atorvastatin magnesium as active ingredient. The atorvastatin magnesium is preferably in crystallised form, fully crystallised or partially crystallised. The crystallised material may comprise one or more polymorphic forms, which have characterised powder X-ray diffraction spectra.
IPC 8 full level
A61K 9/20 (2006.01); C07D 207/34 (2006.01)
CPC (source: EP)
A61K 9/2018 (2013.01); C07D 207/34 (2013.01); C07D 405/06 (2013.01)
Citation (search report)
See references of WO 2008078341A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2008078341 A2 20080703; WO 2008078341 A3 20081224; EP 2124899 A2 20091202; IS 8587 A 20080628
DOCDB simple family (application)
IS 2007000024 W 20071221; EP 07849693 A 20071221; IS 8587 A 20061227